Statement of Ownership (sc 13g)
March 25 2016 - 4:18PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of
1934
CV Sciences, Inc. (formerly CannaVEST Corp.)
(Name of Issuer)
Common Stock
(Title of Class of Securities)
126654102
(CUSIP Number)
March 22, 2016
(Date of Event Which Requires Filing of
this Statement)
Check the appropriate box to designate
the rule pursuant to which this Schedule is filed:
*The remainder of this cover page shall
be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for
any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder
of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange
Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all
other provisions of the Act (however, see the Notes).
CUSIP No. 126654102
|
SCHEDULE 13G
|
Page 2 of 5
|
1
|
NAME OF REPORTING PERSON
Cross & Company
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF
A GROUP
(a)
¨
(b)
¨
|
3
|
SEC USE ONLY
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Nevada
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
:
|
5
|
SOLE VOTING POWER
1,651,231
|
6
|
SHARED VOTING POWER
0
|
7
|
SOLE DISPOSITIVE POWER
1,651,231
|
8
|
SHARED DISPOSITIVE POWER
0
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY
EACH REPORTING PERSON
1,651,231
|
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9)
EXCLUDES CERTAIN SHARES
¨
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT
IN ROW (9)
4.11% (1)
|
12
|
TYPE OF REPORTING PERSON
CO
|
|
|
|
|
|
(1)
|
Based on 40,210,159 shares of common stock outstanding as of December 30, 2015, based on 35,210,159
shares of common stock outstanding as of November 16, 2015, as reported in the Issuer’s Quarterly Report on Form 10-Q filed
on November 16, 2015, and the issuance of 5,000,000 shares of common stock by the Issuer on December 30, 2015, as reported in the
Issuer’s Current Report on Form 8-K filed on January 4, 2016.
|
|
Item 1(a).
|
Name of Issuer:
|
CV Sciences, Inc. (formerly
CannaVEST Corp.), a Delaware corporation
|
Item 1(b).
|
Address of Issuer’s Principal Executive Offices:
|
2688 South Rainbow Boulevard,
Suite B
Las Vegas, Nevada 89146
|
Item 2(a).
|
Name of Person Filing:
|
Cross & Company
|
Item 2(b).
|
Address of Principal Business Office, or if None,
Residence:
|
110 West C Street, Suite
1300
San Diego, California
92101
Cross & Company,
a Nevada corporation
|
Item 2(d).
|
Title of Class of Securities:
|
Common Stock, par value
$0.0001 (the “Common Stock”)
126654102
|
Item 3.
|
If this statement is filed pursuant to 240.13d-1(b)
or 240.13d-2(b) or (c), check whether the person filing is a:
|
Not applicable.
|
(a)
|
Amount Beneficially Owned: 1,651,231 shares of Common
Stock
|
|
(b)
|
Percent of Class: 4.11% (1)
|
|
(c)
|
Number of shares as to which such person has:
|
|
(i)
|
Sole power to vote or to direct the vote: 1,651,231 shares
of Common Stock
|
|
(ii)
|
Shared power to vote or to direct the vote: 0
|
|
(iii)
|
Sole power to dispose or to direct the disposition of:
1,651,231 shares of Common Stock
|
|
(iv)
|
Shared power to dispose or to direct the disposition
of: 0
|
|
Item 5.
|
Ownership of Five Percent or Less of a Class.
|
If this statement is being filed
to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent
of the class of securities, check the following: [
ü
]
|
Item 6.
|
Ownership of More than Five Percent on Behalf of Another
Person.
|
Not applicable.
|
Item 7.
|
Identification and Classification of the Subsidiary
Which Acquired the Security Being Reported on by the Parent Holding Company.
|
Not applicable.
|
Item 8.
|
Identification and Classification of Members of the
Group.
|
Not applicable.
|
Item 9.
|
Notice of Dissolution of Group.
|
Not applicable.
|
(c)
|
By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing
or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant
in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.
|
Signature
After reasonable inquiry
and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: March 25, 2016
|
Cross & Company
|
|
|
|
|
|
|
|
By:
|
/s/ James R. Arabia
|
|
|
James R. Arabia
|
|
|
President
|
CV Sciences (QB) (USOTC:CVSI)
Historical Stock Chart
From Aug 2024 to Sep 2024
CV Sciences (QB) (USOTC:CVSI)
Historical Stock Chart
From Sep 2023 to Sep 2024